Ultra-low-dose anti-VEGF treatment in retinopathy of prematurity.
作者信息
Şahin Alparslan, Şahin Muhammed, Türkcü Fatih Mehmet
机构信息
Department of Ophthalmology, Zilan Private Hospital, Batman, Turkey.
Department of Ophthalmology, School of Medicine, Dicle University, Diyarbakır, Turkey.
出版信息
Eur J Ophthalmol. 2022 Jan;32(1):NP290. doi: 10.1177/1120672119868428. Epub 2019 Aug 5.
PMID:31378076
Abstract
摘要
相似文献
1
Ultra-low-dose anti-VEGF treatment in retinopathy of prematurity.
Eur J Ophthalmol. 2022 Jan;32(1):NP290. doi: 10.1177/1120672119868428. Epub 2019 Aug 5.
2
The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity.英国抗血管内皮生长因子疗法治疗早产儿视网膜病变的实践
Eye (Lond). 2021 Sep;35(9):2451-2453. doi: 10.1038/s41433-021-01543-9. Epub 2021 Apr 20.
3
Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.玻璃体内注射贝伐单抗治疗早产儿视网膜病变：知情同意的考量
Can J Ophthalmol. 2015 Dec;50(6):409-12. doi: 10.1016/j.jcjo.2015.10.004.
4
The Use of Bevacizumab in the Treatment of Retinopathy of Prematurity.
Int Ophthalmol Clin. 2022 Jan 1;62(1):219-230. doi: 10.1097/IIO.0000000000000400.
5
Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?贝伐单抗是否会改变早产儿视网膜病变的血管生成潜能？
Ophthalmology. 2016 Sep;123(9):2042-3. doi: 10.1016/j.ophtha.2016.04.024. Epub 2016 Jun 16.
6
Bevacizumab for retinopathy of prematurity and neurodevelopment.贝伐单抗用于早产儿视网膜病变及神经发育
J AAPOS. 2023 Feb;27(1):1-2. doi: 10.1016/j.jaapos.2023.01.002. Epub 2023 Jan 7.
7
Bevacizumab for retinopathy of prematurity and neurodevelopment.
J AAPOS. 2024 Feb;28(1):103786. doi: 10.1016/j.jaapos.2023.08.018. Epub 2023 Nov 4.
8
Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.玻璃体内注射贝伐单抗治疗早产儿视网膜病变和肺动脉高压。
J Perinatol. 2023 Feb;43(2):236-237. doi: 10.1038/s41372-022-01489-0. Epub 2022 Aug 15.
9
A lower dose of intravitreal bevacizumab effectively treats retinopathy of prematurity.较低剂量的玻璃体内注射贝伐单抗可有效治疗早产儿视网膜病变。
J AAPOS. 2016 Dec;20(6):490-492. doi: 10.1016/j.jaapos.2016.09.012. Epub 2016 Oct 26.
10
Re: Freedman et al: Low- and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes (Ophthalmology. 2022;129:1120-1128).回复：弗里德曼等人：低剂量和极低剂量贝伐单抗治疗早产儿视网膜病变：复发、额外治疗及12个月结局（《眼科学》。2022年；129卷：1120 - 1128页）
Ophthalmology. 2023 May;130(5):e18. doi: 10.1016/j.ophtha.2022.12.016. Epub 2023 Jan 24.
Zotero 插件